UK Biotechs Look Destined To Remain Bit Players
GW Pharma And Kymab Sold In Less Than A Month
Another promising British-based company, GW Pharma, has been acquired, this time by mid-sized US player Jazz. Is it a pipedream that a UK biotech could be in a position to pull off a $7bn takeover of its own or does it really not matter?
